AusPAR Attachment 2: Extract from the Clinical Evaluation ...

Treatment of acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and prevention of related death. Prevention of recurrent deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and related death. Dosage forms and strengths. The following dosage forms and strengths are currently registered in Australia: capsules containing 75 mg, 110 mg and 150 mg of DE. No new dosage forms … ................
................